Yiou René, Loche Catherine-Marie, Lingombet Odile, Abbou Claude, Salomon Laurent, de la Taille Alexandre, Audureau Etienne
Assistance Publique des Hôpitaux de Paris, Urology Department and CRCDC, Henri Mondor Teaching Hospital, Créteil, France.
Neurourol Urodyn. 2015 Jan;34(1):12-7. doi: 10.1002/nau.22503. Epub 2013 Oct 19.
To evaluate stress urinary incontinence (SUI), overactive bladder (OAB), and obstructive symptoms in patients with post-radical prostatectomy urinary incontinence (pRP-UI) treated with the bulbar compressive sling TOMS, and investigate the effect of each urinary symptom on urinary bother.
We prospectively followed 40 patients with pRP-UI before, and 6 and 12 months (T6 and T12, respectively) after implantation of the TOMS sling. Urinary symptoms were evaluated using the following questionnaires: USP, ICIQ, UCLA-PCI (urinary bother domain), PGI-I, and daily pad use. Success was defined as patients wearing no pads or using one security pad.
Significant improvement of mean USP-SUI (6.97/9, 3.35, 3.02, P < 0.001) and USP-OAB domains (8.1/21, 5.74, 5.71, P < 0.001), ICIQ (15.15/21, 8.17/21, 8.35/21, P < 0.01), urinary bother (92.5/100, 42.5, 41.87, P < 0.001), and pad number (2.78, 1.01, 1.03, P < 0.001) were noted between baseline, T6, and T12. At baseline, 32 (80%) patients reported urge incontinence. Urinary bother strongly correlated with UPS-SUI but not with UPS-OAB score. At T12, 22 (55%) patients with pad use were considered cured, and 13 (32.5%) patients reported a greatly improved urinary tract condition (PGI-I). Improvement of USP-SUI and USP-OAB scores correlated with improvement of ICIQ and PGI scores. The USP-obstructive domain remained unchanged.
The TOMS sling improves SUI and OAB symptoms without generating obstructive symptoms. OAB symptoms including urge incontinence reported by most patients were not a major concern at baseline; however, improvement of these symptoms was associated with improvement of continence and PGI-I scores.
评估接受球部压迫吊带TOMS治疗的根治性前列腺切除术后尿失禁(pRP-UI)患者的压力性尿失禁(SUI)、膀胱过度活动症(OAB)及梗阻性症状,并研究每种泌尿系统症状对排尿困扰的影响。
我们对40例pRP-UI患者在植入TOMS吊带前、植入后6个月和12个月(分别为T6和T12)进行前瞻性随访。使用以下问卷评估泌尿系统症状:美国泌尿外科学会尿失禁问卷(USP)、国际尿失禁咨询委员会问卷(ICIQ)、加州大学洛杉矶分校前列腺癌指数(UCLA-PCI,排尿困扰领域)、患者总体印象-改善(PGI-I)以及每日护垫使用情况。成功定义为患者无需使用护垫或仅使用一片备用护垫。
在基线、T6和T12之间,平均USP-SUI(6.97/9、3.35、3.02,P<0.001)和USP-OAB领域(8.1/21、5.74、5.71,P<0.001)、ICIQ(15.15/21、8.17/21、8.35/21,P<0.01)、排尿困扰(92.5/100、42.5、41.87,P<0.001)以及护垫使用数量(2.78、1.01、1.03,P<0.001)均有显著改善。基线时,32例(80%)患者报告有急迫性尿失禁。排尿困扰与USP-SUI密切相关,但与USP-OAB评分无关。在T12时,22例(55%)使用护垫的患者被认为治愈,13例(32.5%)患者报告尿路状况有显著改善(PGI-I)。USP-SUI和USP-OAB评分的改善与ICIQ和PGI评分的改善相关。USP梗阻领域无变化。
TOMS吊带可改善SUI和OAB症状,且不会产生梗阻性症状。大多数患者报告的包括急迫性尿失禁在内的OAB症状在基线时并非主要问题;然而,这些症状的改善与尿失禁和PGI-I评分的改善相关。